Patients who develop anti-CTLA-4 associated endocrinopathies may present with nonspecific symptoms such as fatigue, weakness, headache, nausea, behavioral changes, visual impairments, memory loss, decreased libido, anorexia, insomnia, and cold or heat intolerance. The gene discussed is CTLA4; the disease is Visual impairment.